Chromadex Corporation operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Chromadex with three other
companies in this sector in the United States:
Fitlife Brands Inc
sales of $17.08 million
During the year ended December of 2018, sales at
Chromadex were $31.56 million.
increase of 48.8%
versus 2017, when the company's sales were $21.20 million.
Sales of Consumer Products Segments saw an increase
that was more than double the company's growth rate: sales were up
237.6% in 2018, from
$5.46 million to $18.45 million.
Not all segments of Chromadex experienced an increase in sales in 2018:
sales of Ingredients Segments fell 23.2% to $8.57 million.
Chromadex also experienced decreases in sales in
Core Standards, Contract Services and Ingr (down 0.9% to $4.54 million)